Patent US4119723A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4119723A Expired / Lapsed US ⏱️ 0.0 years remaining

Treatment of rheumatoid arthritis and related diseases

Assignee: Individual
•
Filing: 1977-07-08
•
Granted: 1978-10-10
•
Expires: 1997-07-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract It is believed that rheumatoid arthritis and related collagen and auto-immune diseases are an infection and that various species of free-living (limax) amoebae are the aetiological agent of these diseases. It has been discovered that tinidazole and related compounds, antimycotic drugs with anti-protozoal activity, are effective for the treatment of rheumatoid arthritis and other collagen and auto-immune (rheumatoid) diseases.

Inventors

  • 👤 Roger Wyburn-Mason

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 13:10
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/41; A61K31/415

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 56 words
A method for producing remission in patients suffering from active rheumatoid arthritis which comprises administering orally to such a patient an effective amount of a compound of the formula: ##STR3## wherein R and R' are each alkylene having 1 to 7 carbon atoms and X is lower alkylsulfonyl and the pharmaceutically acceptable acid addition salt thereof.
Claim 2
Independent Claim 56 words
A method for producing remission in patients suffering from active rheumatoid arthritis which comprises administering orally to such a patient an effective amount of a compound of the formula: ##STR3## wherein R and R' are each alkylene having 1 to 7 carbon atoms and X is lower alkylsulfonyl and the pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 23 words
The method of claim 1 wherein R is alkylene having 1 to 7 carbon atoms, X is lower alkylsulfonyl and R' is methylene.
Claim 4
Dependent Claim 15 words
The method according to claim 1 wherein the compound is tinidazole having the formula: ##STR4##
Claim 5
Dependent Claim 31 words
The method of claim 1, wherein the compound is tinidazole having the formula: ##STR5## and is administered orally in doses of approximately 35 mg. per kilogram of body weight per week.
Claim 6
Dependent Claim 35 words
The method of combating rheumatoid arthritis of claim 4 which comprises orally administering to the infected subject tinidazole in a weekly dose amount of about 20 to about 50 miligrams per kilogram of body weight.

References Cited (Backward Citations)

US3376311A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-10-09 1982-04-10 1982-10-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-10-09 1986-04-10 1986-10-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-10-09 1990-04-10 1990-10-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag